High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: carboplatin, thiotepa, and cyclophosphamide|DRUG: chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
Sponsor: The Netherlands Cancer Institute